Gerald L. Messerschmidt

Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimen

Robert F. Ozols, Albert Deisseroth, Nasser Javadpour et al. · Cancer · 1983 · 145 citations · Full text

Cancer Management, Pathology, Pharmacotherapy +16

Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma

Harry W. Snyder, A Mittelman, Gerald L. Messerschmidt et al. · Cancer · 1993 · 107 citations · Full text

Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer

Joseph P. Balint, Elizabeth S. Gabitzsch, Adrian Rice et al. · Cancer Immunology Immunotherapy · 2015 · 53 citations · Full text

Phase 1/2, Extended Evaluation, Medicine +9

Protein A immunoadsorption in the treatment of malignant disease.

Gerald L. Messerschmidt, David H. Henry, Harry W. Snyder et al. · Journal of Clinical Oncology · 1988 · 51 citations

Immune Evasion, Cancer Immunosurveillance, Malignant Disease +15

Acute neurologic dysfunction after high-dose etoposide therapy for malignant glioma

Richard Leff, James Thompson, Mary B. Daly et al. · Cancer · 1988 · 48 citations · Full text

Pharmacotherapy, High-grade Gliomas, Brain Lesion +16